Millepachine

Name: Millepachine
Brand: MedChemExpress
SKU: HY-N7591
Rating: 4.5 (1 reviews)

Cat. No.: HY-N7591 Purity: 99.55%: FAQs
Data Sheet SDS COA Handling Instructions

Molarity Calculator

Millepachine is a bioactive natural chalcone from Chinese herbal medicine Millettia pachycarpa Benth, exhibits strong antitumor effects against numerous human cancer cells both in vitro and in vivo.

For research use only. We do not sell to patients.

Millepachine Chemical Structure

CAS No. : 1393922-01-4

Size	Price	Stock	Quantity
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO ready for reconstitution	USD 220	In-stock	Estimated Time of Arrival: December 31
Solution
10 mM * 1 mL in DMSO	USD 220	In-stock	Estimated Time of Arrival: December 31
Solid
5 mg	USD 200	In-stock	Estimated Time of Arrival: December 31
10 mg	USD 320	In-stock	Estimated Time of Arrival: December 31
50 mg	USD 800	In-stock	Estimated Time of Arrival: December 31
100 mg	USD 1200	In-stock	Estimated Time of Arrival: December 31
200 mg		Get quote
500 mg		Get quote

or Bulk Inquiry

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

Biological Activity
Purity & Documentation
References
Customer Review

Description

Cellular Effect

Cell Line	Type	Value	Description	References
A2780	IC₅₀	3.09 μM Compound: Millepachine	Antiproliferative activity against human A2780 cells assessed as cell viability incubated for 48 hrs by MTT assay Antiproliferative activity against human A2780 cells assessed as cell viability incubated for 48 hrs by MTT assay	[PMID: 35282680]
A-375	IC₅₀	3.58 μM Compound: Millepachine	Cytotoxicity against human A375 cells by MTT assay Cytotoxicity against human A375 cells by MTT assay	[PMID: 23425970]
A-375	IC₅₀	3580 nM Compound: 1	Antiproliferative activity against human A375 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay Antiproliferative activity against human A375 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay	[PMID: 25208345]
A549	IC₅₀	3.95 μM Compound: Millepachine	Antiproliferative activity against human A549 cells assessed as cell viability incubated for 48 hrs by MTT assay Antiproliferative activity against human A549 cells assessed as cell viability incubated for 48 hrs by MTT assay	[PMID: 35282680]
HCT-116	IC₅₀	4.66 μM Compound: Millepachine	Antiproliferative activity against human HCT116 cells after 24 hrs by MTT assay Antiproliferative activity against human HCT116 cells after 24 hrs by MTT assay	[PMID: 22784822]
HCT-8	IC₅₀	5.02 μM Compound: Millepachine	Antiproliferative activity against human HCT-8 cells assessed as cell viability incubated for 48 hrs by MTT assay Antiproliferative activity against human HCT-8 cells assessed as cell viability incubated for 48 hrs by MTT assay	[PMID: 35282680]
HeLa	IC₅₀	6.03 μM Compound: Millepachine	Antiproliferative activity against human HeLa cells assessed as cell viability incubated for 48 hrs by MTT assay Antiproliferative activity against human HeLa cells assessed as cell viability incubated for 48 hrs by MTT assay	[PMID: 35282680]
HepG2	IC₅₀	1.51 μM Compound: Millepachine	Antiproliferative activity against human HepG2 cells after 24 hrs by MTT assay Antiproliferative activity against human HepG2 cells after 24 hrs by MTT assay	[PMID: 24629450]
HepG2	IC₅₀	1.51 μM Compound: Millepachine	Antiproliferative activity against human HepG2 cells after 24 hrs by MTT assay Antiproliferative activity against human HepG2 cells after 24 hrs by MTT assay	[PMID: 22784822]
HepG2	IC₅₀	1.51 μM Compound: Millepachine	Cytotoxicity against human HepG2 cells by MTT assay Cytotoxicity against human HepG2 cells by MTT assay	[PMID: 23425970]
HepG2	IC₅₀	1510 nM Compound: 1	Antiproliferative activity against human HepG2 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay Antiproliferative activity against human HepG2 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay	[PMID: 25208345]
HepG2	IC₅₀	4.54 μM Compound: 1a	Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay	[PMID: 28340411]
HT-29	IC₅₀	3.29 μM Compound: Millepachine	Antiproliferative activity against human HT-29 cells after 24 hrs by MTT assay Antiproliferative activity against human HT-29 cells after 24 hrs by MTT assay	[PMID: 22784822]
K562	IC₅₀	4.56 μM Compound: Millepachine	Antiproliferative activity against human K562 cells after 24 hrs by MTT assay Antiproliferative activity against human K562 cells after 24 hrs by MTT assay	[PMID: 22784822]
K562	IC₅₀	4.56 μM Compound: Millepachine	Cytotoxicity against human K562 cells by MTT assay Cytotoxicity against human K562 cells by MTT assay	[PMID: 23425970]
K562	IC₅₀	4560 nM Compound: 1	Antiproliferative activity against human K562 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay Antiproliferative activity against human K562 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay	[PMID: 25208345]
L02	IC₅₀	> 20 μM Compound: Millepachine	Cytotoxicity against human LO2 cells by MTT assay Cytotoxicity against human LO2 cells by MTT assay	[PMID: 23425970]
L02	IC₅₀	25.05 μM Compound: 1a	Cytotoxicity against human HL7702 cells after 48 hrs by MTT assay Cytotoxicity against human HL7702 cells after 48 hrs by MTT assay	[PMID: 28340411]
MCF7	IC₅₀	6.98 μM Compound: Millepachine	Antiproliferative activity against human MCF7 cells assessed as cell viability incubated for 48 hrs by MTT assay Antiproliferative activity against human MCF7 cells assessed as cell viability incubated for 48 hrs by MTT assay	[PMID: 35282680]
MGC-803	IC₅₀	10.98 μM Compound: 1a	Cytotoxicity against human MGC803 cells after 48 hrs by MTT assay Cytotoxicity against human MGC803 cells after 48 hrs by MTT assay	[PMID: 28340411]
NCI-H460	IC₅₀	7.65 μM Compound: 1a	Cytotoxicity against human NCI-H460 cells after 48 hrs by MTT assay Cytotoxicity against human NCI-H460 cells after 48 hrs by MTT assay	[PMID: 28340411]
SK-OV-3	IC₅₀	2.36 μM Compound: Millepachine	Antiproliferative activity against human SKOV3 cells after 24 hrs by MTT assay Antiproliferative activity against human SKOV3 cells after 24 hrs by MTT assay	[PMID: 22784822]
SK-OV-3	IC₅₀	9.85 μM Compound: 1a	Cytotoxicity against human SKOV3 cells after 48 hrs by MTT assay Cytotoxicity against human SKOV3 cells after 48 hrs by MTT assay	[PMID: 28340411]
SW-620	IC₅₀	0.76 μM Compound: Millepachine	Antiproliferative activity against human SW620 cells after 24 hrs by MTT assay Antiproliferative activity against human SW620 cells after 24 hrs by MTT assay	[PMID: 22784822]
T-24	IC₅₀	11.05 μM Compound: 1a	Cytotoxicity against human T24 cells after 48 hrs by MTT assay Cytotoxicity against human T24 cells after 48 hrs by MTT assay	[PMID: 28340411]

In Vitro

Millepachine (1.25-20 μM; 48 h) remarkably inhibits the proliferation of cisplatin-resistant A2780CP cells^[1].
Millepachine (2-8 μM; 24 or 48 h) induces G2/M arrest and apoptosis cisplatin-sensitive A2780S and cisplatin-resistant A2780CP cells^[1].
Millepachine (2-8 μM; 24 h) decreases topoisomerase II levels in A2780S and A2780CP cells^[1].
Millepachine (2-8 μM; 24 h) inhibits ATP-binding cassette transporter activity in A2780CP cells^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Proliferation Assay^[1]

Cell Line:	A2780CP cells
Concentration:	0, 1.25, 2.5, 5, 10, 20 μM
Incubation Time:	48 hours
Result:	Inhibited the cells proliferation with an IC₅₀ of 4 μM.

Cell Cycle Analysis^[1]

Cell Line:	A2780S and A2780CP cells
Concentration:	2, 4, 8 μM
Incubation Time:	24 or 48 hours
Result:	Induced significant G2/M arrest both in both cells. The percentage of cells in the G2/M fraction increased from 15.99% in vehicle cells to 24.93%, 60.67%, and 77.31% at dose of 2, 4, and 8 μM in A2780S cells, respectively.

Apoptosis Analysis^[1]

Cell Line:	A2780S and A2780CP cells
Concentration:	2, 4, 8 μM
Incubation Time:	24 or 48 hours
Result:	The percentage of apoptotic cells increased from 1.49% in vehicle cells to 10.98%, 20.60%, and 39.43% at dose of 2, 4, and 8 μM in A2780S cells, respectively. The percentage of apoptotic cells increased from 0.87% to 10.97%, 25.28%, and 37.59% in A2780CP cells, respectively.

Western Blot Analysis^[1]

Cell Line:	A2780S and A2780CP cells
Concentration:	0, 2, 4, 8 μM
Incubation Time:	24 hours
Result:	Decreased the levels of topoisomerase II (TOPO II) in both cells.

In Vivo

Millepachine (20 mg/kg; i.v. every two days for 14 day) inhibits tumor growth in mice^[1].
Millepachine (20 mg/kg; i.v. every two days for 14 day) does not induce acquired drug resistance in an excised A2780S xenograft model^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	Female BALB/c nude mice (6 weeks) are injected A2780S or A2780CP cells^[1]
Dosage:	20 mg/kg
Administration:	I.v. every two days for 2-14 days
Result:	Reduced tumor volume and tumor weight with the inhibitory rate of 73.21% and 65.58% in A2780S (after seven times injection) and A2780CP (after six times injection) xenograft model, respectively. With low toxicity in vivo.

Molecular Weight

350.41

Formula

C₂₂H₂₂O₄

CAS No.

1393922-01-4

Appearance

Solid

Color

Light yellow to yellow

SMILES

O=C(C1=C2C(C=CC(C)(C)O2)=C(OC)C=C1)/C=C/C3=CC=C(OC)C=C3

Structure Classification

Initial Source

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

Solvent & Solubility

In Vitro:

DMSO : 100 mg/mL (285.38 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	2.8538 mL	14.2690 mL	28.5380 mL
5 mM	0.5708 mL	2.8538 mL	5.7076 mL
10 mM	0.2854 mL	1.4269 mL	2.8538 mL

View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Molarity Calculator
Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

Concentration _(start)

Volume _(start)

Concentration _(final)

Volume _(final)

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: 2.5 mg/mL (7.13 mM); Suspended solution; Need ultrasonic

This protocol yields a suspended solution of 2.5 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Protocol 2

Add each solvent one by one: 10% DMSO 90% Corn Oil
Solubility: ≥ 2.5 mg/mL (7.13 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL Corn oil, and mix evenly.

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Please enter your animal formula composition:

DMSO +

Tween-80 +

Saline

Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.

The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).

Calculation results:

Working solution concentration: mg/mL

Method for preparing stock solution: mg drug dissolved in μL DMSO (Stock solution concentration: mg/mL).

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).

Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.

If the continuous dosing period exceeds half a month, please choose this protocol carefully.

Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.

Purity & Documentation

Purity: 99.55%

Select Batch:

Data Sheet (278 KB) SDS (393 KB)

COA (251 KB) RP-HPLC (249 KB)

Handling Instructions (2659 KB)

References

[1]. Wu W, et, al. Millepachine showed novel antitumor effects in cisplatin-resistant human ovarian cancer through inhibiting drug efflux function of ATP-binding cassette transporters. Phytother Res. 2018 Dec; 32(12):2428-2435. [Content Brief]

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg

DMSO	1 mM	2.8538 mL	14.2690 mL	28.5380 mL	71.3450 mL
	5 mM	0.5708 mL	2.8538 mL	5.7076 mL	14.2690 mL
	10 mM	0.2854 mL	1.4269 mL	2.8538 mL	7.1345 mL
	15 mM	0.1903 mL	0.9513 mL	1.9025 mL	4.7563 mL
	20 mM	0.1427 mL	0.7134 mL	1.4269 mL	3.5672 mL
	25 mM	0.1142 mL	0.5708 mL	1.1415 mL	2.8538 mL
	30 mM	0.0951 mL	0.4756 mL	0.9513 mL	2.3782 mL
	40 mM	0.0713 mL	0.3567 mL	0.7134 mL	1.7836 mL
	50 mM	0.0571 mL	0.2854 mL	0.5708 mL	1.4269 mL
	60 mM	0.0476 mL	0.2378 mL	0.4756 mL	1.1891 mL
	80 mM	0.0357 mL	0.1784 mL	0.3567 mL	0.8918 mL
	100 mM	0.0285 mL	0.1427 mL	0.2854 mL	0.7134 mL

Millepachine Related Classifications

Help & FAQs

Do most proteins show cross-species activity?
Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Millepachine1393922-01-4ApoptosisbioactivenaturalchalconeChineseherbalmedicineMillettiapachycarpaBenthantitumorcancerInhibitorinhibitorinhibit

Please select a local distributor ナミキ商事株式会社コスモ・バイオ株式会社
Product Name			Salutation
Applicant Name *			Email Address *
Phone Number *			Organization Name *
Department *			Requested quantity *
Country or Region *
Remarks

Product Name			Lot #
Applicant Name *			Email Address *
Phone Number			Department *
Organization Name *			Country or Region *
Remarks

Name
Email *

	Sorry, but the email address you supplied was invalid.

Millepachine

Customer Review

Millepachine Related Antibodies

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

Biological Activity

Purity & Documentation

References

Customer Review

Millepachine Related Antibodies

Molarity Calculator

Dilution Calculator

Complete Stock Solution Preparation Table

Millepachine Related Classifications

Keywords:

Your Recently Viewed Products:

Customer Review

Request for HNMR Report

SAFETY DATA SHEET (SDS)

Request for HNMR Report